MYX 3.56% $4.60 mayne pharma group limited

My rough figures indicate EPS for FY14 could be in the range of...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 424 Posts.
    My rough figures indicate EPS for FY14 could be in the range of $0.03 (17m annualised NPAT / 563m shares on issue).

    This would be in line with forecasts I think and would put it on a p/e of approx. 24x.

    I think it's fairly priced but with a good growth profile.

 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.